IRIS Accounts Production v23.3.1.45 07416633 director 1.12.22 30.11.23 30.11.23 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074166332022-11-30074166332023-11-30074166332022-12-012023-11-30074166332021-11-30074166332021-12-012022-11-30074166332022-11-3007416633ns10:Originalns15:EnglandWales2022-12-012023-11-3007416633ns14:PoundSterlingns10:Original2022-12-012023-11-3007416633ns10:Originalns10:Director12022-12-012023-11-3007416633ns10:Original2022-12-012023-11-3007416633ns10:Original2023-11-3007416633ns10:Originalns10:PrivateLimitedCompanyLtd2022-12-012023-11-3007416633ns10:Originalns10:SmallEntities2022-12-012023-11-3007416633ns10:Originalns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3007416633ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3007416633ns10:SmallCompaniesRegimeForAccountsns10:Original2022-12-012023-11-3007416633ns10:Originalns10:FullAccounts2022-12-012023-11-3007416633ns10:Original12022-12-012023-11-3007416633ns10:Originalns10:OrdinaryShareClass12022-12-012023-11-3007416633ns10:Originalns10:RegisteredOffice2022-12-012023-11-3007416633ns10:Original2022-11-3007416633ns10:Originalns5:CurrentFinancialInstruments2023-11-3007416633ns10:Originalns5:CurrentFinancialInstruments2022-11-3007416633ns5:ShareCapitalns10:Original2023-11-3007416633ns5:ShareCapitalns10:Original2022-11-3007416633ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-11-3007416633ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-11-3007416633ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-12-012023-11-3007416633ns10:Originalns5:PlantMachinery2022-12-012023-11-3007416633ns10:Originalns5:ComputerEquipment2022-12-012023-11-3007416633ns10:Original2021-12-012022-11-3007416633ns10:Originalns5:NetGoodwill2022-11-3007416633ns10:Originalns5:NetGoodwill2023-11-3007416633ns10:Originalns5:NetGoodwill2022-11-3007416633ns10:Originalns5:PlantMachinery2022-11-3007416633ns10:Originalns5:PlantMachinery2023-11-3007416633ns10:Originalns5:PlantMachinery2022-11-3007416633ns10:Originalns10:OrdinaryShareClass12023-11-30
REGISTERED NUMBER: 07416633 (England and Wales)









UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2023

FOR

SHERGILL ORTHOPAEDICS LIMITED

SHERGILL ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 07416633)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SHERGILL ORTHOPAEDICS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2023







DIRECTOR: G S Shergill





REGISTERED OFFICE: Windover House
St. Ann Street
Salisbury
SP1 2DR





REGISTERED NUMBER: 07416633 (England and Wales)





ACCOUNTANTS: Fawcetts LLP
Chartered Accountants
Windover House
St. Ann Street
Salisbury
SP1 2DR

SHERGILL ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 07416633)

BALANCE SHEET
30 NOVEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 135 169
135 169

CURRENT ASSETS
Cash at bank 111,063 180,045

CREDITORS
Amounts falling due within one year 6 2,116 4,396
NET CURRENT ASSETS 108,947 175,649
TOTAL ASSETS LESS CURRENT LIABILITIES 109,082 175,818

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 108,982 175,718
SHAREHOLDERS' FUNDS 109,082 175,818

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SHERGILL ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 07416633)

BALANCE SHEET - continued
30 NOVEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 February 2024 and were signed by:





G S Shergill - Director


SHERGILL ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 07416633)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023


1. STATUTORY INFORMATION

Shergill Orthopaedics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis and are presented in Sterling (£) which is the functional currency of the company.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


SHERGILL ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 07416633)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Debtors
Debtors are measured at their recoverable amount.

Creditors and provisions
Creditors and provisions are recognised where the company has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 December 2022
and 30 November 2023 10,000
AMORTISATION
At 1 December 2022
and 30 November 2023 10,000
NET BOOK VALUE
At 30 November 2023 -
At 30 November 2022 -

SHERGILL ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 07416633)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2022
and 30 November 2023 10,649
DEPRECIATION
At 1 December 2022 10,480
Charge for year 34
At 30 November 2023 10,514
NET BOOK VALUE
At 30 November 2023 135
At 30 November 2022 169

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security - 2,669
Other creditors 2,116 1,727
2,116 4,396

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100

8. RELATED PARTY DISCLOSURES

Included in creditors due within one year is an amount of £916 (2022 - £227) due to the director.